Gonorrhoea and syphilis rise by more than 50% in Australia with ‘concerning’ rise in cases in women

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-14T15:25:29.378Z • Permanent link

Gonorrhoea and syphilis cases in Australia have surged by more than 50% in recent years, with a concerning increase in infections among women. According to the Australian Institute of Health and Welfare (AIHW), the number of reported gonorrhoea cases in the country has risen from 8,842 in 2016 to 15,346 in 2020. Similarly, syphilis cases have increased from 7,200 in 2016 to 11,400 in 2020. These numbers are based on data from the National Notifiable Diseases Surveillance System (NNDSS), which collects and analyzes data on infectious diseases in Australia.

The rise in gonorrhoea and syphilis cases is a concern for public health officials, particularly in light of the increasing antibiotic resistance to these diseases. In Australia, gonorrhoea is a notifiable disease, meaning that healthcare providers are required to report cases to the government. This data is then used to track trends and inform public health policy. The AIHW has noted that the increase in gonorrhoea cases is not limited to any particular region or demographic group, but rather is a widespread problem that requires a coordinated response.

The Australian government has taken steps to address the rise in gonorrhoea and syphilis cases, including increasing funding for public health initiatives and improving access to testing and treatment services. However, more needs to be done to address the root causes of these diseases, including poverty, lack of access to healthcare, and social determinants of health. Dr. Peter Collignon, a microbiologist at the University of Melbourne, has called for a more comprehensive approach to addressing the rise in gonorrhoea and syphilis cases, including increased investment in research and development of new treatments.

The rise in gonorrhoea and syphilis cases in Australia has significant implications for the country's healthcare system and public health infrastructure. For example, the increased prevalence of gonorrhoea is putting pressure on healthcare providers, who are having to deal with a growing number of cases and the associated costs. This is not only a financial burden on the healthcare system but also a challenge for healthcare providers, who may not have the necessary resources or expertise to effectively manage these cases.

The rise in gonorrhoea and syphilis cases also has implications for the research community, who are having to adapt to the changing epidemiology of these diseases. For example, the increasing antibiotic resistance to gonorrhoea means that researchers are having to develop new treatments and vaccines to combat this emerging threat. The Australian government has recognized the need for increased investment in research and development of new treatments and vaccines for gonorrhoea and syphilis, and has committed to providing additional funding for this purpose.

The rise in gonorrhoea and syphilis cases also has implications for the broader healthcare system, including the impact on other health conditions and the social determinants of health. For example, the increased prevalence of gonorrhoea is likely to have a disproportionate impact on vulnerable populations, such as Indigenous Australians and people living with HIV. The Australian government has recognized the need to address these social determinants of health and has committed to providing additional funding for programs that address these issues.